Cite this article
-
APA : Zahid, D., Tahir, R., & Ashfaq, W. (2024). Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities. Global Pharmaceutical Sciences Review, IX(II), 18-29. https://doi.org/10.31703/gpsr.2024(IX-II).03
-
CHICAGO : Zahid, Dua, Rabia Tahir, and Wajiha Ashfaq. 2024. "Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities." Global Pharmaceutical Sciences Review, IX (II): 18-29 doi: 10.31703/gpsr.2024(IX-II).03
-
HARVARD : ZAHID, D., TAHIR, R. & ASHFAQ, W. 2024. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities. Global Pharmaceutical Sciences Review, IX, 18-29.
-
MHRA : Zahid, Dua, Rabia Tahir, and Wajiha Ashfaq. 2024. "Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities." Global Pharmaceutical Sciences Review, IX: 18-29
-
MLA : Zahid, Dua, Rabia Tahir, and Wajiha Ashfaq. "Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities." Global Pharmaceutical Sciences Review, IX.II (2024): 18-29 Print.
-
OXFORD : Zahid, Dua, Tahir, Rabia, and Ashfaq, Wajiha (2024), "Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities", Global Pharmaceutical Sciences Review, IX (II), 18-29
-
TURABIAN : Zahid, Dua, Rabia Tahir, and Wajiha Ashfaq. "Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities." Global Pharmaceutical Sciences Review IX, no. II (2024): 18-29. https://doi.org/10.31703/gpsr.2024(IX-II).03